SE429195B - Forfarande for framstellning av ett tverbundet hemoglobinmaterial - Google Patents

Forfarande for framstellning av ett tverbundet hemoglobinmaterial

Info

Publication number
SE429195B
SE429195B SE7404933A SE7404933A SE429195B SE 429195 B SE429195 B SE 429195B SE 7404933 A SE7404933 A SE 7404933A SE 7404933 A SE7404933 A SE 7404933A SE 429195 B SE429195 B SE 429195B
Authority
SE
Sweden
Prior art keywords
procedure
manufacturing
cross
hemoglobin material
bonded
Prior art date
Application number
SE7404933A
Other languages
English (en)
Inventor
A Mazur
Original Assignee
Community Blood Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Community Blood Council filed Critical Community Blood Council
Publication of SE429195B publication Critical patent/SE429195B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SE7404933A 1973-04-11 1974-04-10 Forfarande for framstellning av ett tverbundet hemoglobinmaterial SE429195B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35022573A 1973-04-11 1973-04-11
US442276A US3925344A (en) 1973-04-11 1974-02-13 Plasma protein substitute

Publications (1)

Publication Number Publication Date
SE429195B true SE429195B (sv) 1983-08-22

Family

ID=26996533

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404933A SE429195B (sv) 1973-04-11 1974-04-10 Forfarande for framstellning av ett tverbundet hemoglobinmaterial

Country Status (9)

Country Link
US (1) US3925344A (sv)
BR (1) BR7402876D0 (sv)
CA (1) CA1033721A (sv)
DE (1) DE2417619C2 (sv)
FR (1) FR2225171B1 (sv)
GB (1) GB1427903A (sv)
NL (1) NL7404140A (sv)
SE (1) SE429195B (sv)
SU (1) SU629854A3 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4009267A (en) * 1975-09-09 1977-02-22 Diagnostic Data, Inc. Cross-linked orgotein
CA1055932A (en) * 1975-10-22 1979-06-05 Hematech Inc. Blood substitute based on hemoglobin
US4343715A (en) * 1980-10-10 1982-08-10 Duke University Immobilized hemoglobin, and processes for extracting oxygen from fluids using the same
US4427416A (en) 1980-10-10 1984-01-24 Duke University Processes for extracting oxygen from fluids using immobilized hemoglobin
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
DE3320752A1 (de) * 1983-06-09 1984-12-13 Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
EP0302734B1 (en) * 1987-08-06 1993-10-20 Oxygenetics Inc. Continuous processes for modifying biologically active materials and the products therefrom
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
HUT64571A (en) * 1990-11-29 1994-01-28 Upjohn Co A method for producing hemoglobin preparatives containing imido ester cross bind
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
AU693354B2 (en) * 1995-04-10 1998-06-25 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
EP0854151A1 (de) 1997-01-20 1998-07-22 SanguiBioTech AG Verfahren zur Gewinnung einheitlicher Fraktionen hyperpolymerer Hämoglobine
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
ATE302019T1 (de) * 1997-02-28 2005-09-15 Univ California Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
CA2233725A1 (en) * 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
AU2003207503A1 (en) * 2002-01-11 2003-07-30 Sangart, Inc. Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
EP1472280A4 (en) * 2002-01-11 2005-09-21 Sangart Inc OXYGEN TRANSPORT METHODS AND COMPOSITIONS COMPRISING AN OXYGEN TRANSPORTER AND A CRYSTALLOID IN HYPERTONIC SOLUTION
SI1465643T1 (sl) 2002-01-11 2008-06-30 Sangart Inc Postopki in sestavki za transport kisika z visokoafiniteto za kisik
US20030153491A1 (en) 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US7135554B1 (en) * 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
ES2347805T3 (es) * 2004-08-31 2010-11-04 Sangart, Inc. Metodos para aumentar la estabilidad hemodinamica usando composiciones que transportan oxigeno.
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
AU2014259617B2 (en) 2013-05-03 2019-04-11 Washington University Blood substitute composition and method of use
RU2749266C1 (ru) * 2020-02-10 2021-06-07 Богдан Иванович Асатуров Способ получения биоплазмозаменителя гемодинамического действия

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE945650C (de) * 1952-01-24 1956-07-12 Charles B Knox Gelatine Co Inc Verfahren zur Herstellung von als Blutplasmastreckmittel dienenden serologisch vertraeglichen Proteinderivaten
SE343210B (sv) * 1967-12-20 1972-03-06 Pharmacia Ab

Also Published As

Publication number Publication date
FR2225171A1 (sv) 1974-11-08
SU629854A3 (ru) 1978-10-25
CA1033721A (en) 1978-06-27
DE2417619C2 (de) 1986-10-23
BR7402876D0 (pt) 1974-12-03
GB1427903A (en) 1976-03-10
FR2225171B1 (sv) 1977-08-12
DE2417619A1 (de) 1974-10-31
US3925344A (en) 1975-12-09
NL7404140A (sv) 1974-10-15

Similar Documents

Publication Publication Date Title
SE429195B (sv) Forfarande for framstellning av ett tverbundet hemoglobinmaterial
SE391674B (sv) Maskin for kontinuerlig tillverkning av ihaliga element, innefattande en formningsdon vars formningsyta utgores av ett kontinuerligt band lindat i skruvform pa en uppsettning valsar
SE448790B (sv) Forfarande for framstellning av ett dokument
SE442678B (sv) Forfarande for framstellning av en molekylseparator
FI53654C (sv) Foerfarande foer framstaellning av en operationstextil foer engaongsbruk
BE816822A (fr) Melanges a fumer
SE407156B (sv) Forfarande for framstellning av en silverkatalysator
RO72710A (ro) Procedeu de preparare a 2-carboxietil-n-fosfonometiglicinatului
SE407348B (sv) Bandgjutmaskin
SE425206B (sv) Forfarande for framstellning av ett kottliknande fodermedel
FI56405B (fi) Ett varpstickat material
NO141226C (no) Broennkonstruksjon for en produksjonsbroenn
RO71807A (ro) Procedeu de preparare a izoprenului
DK148057C (da) Emballagefremstillingsmaskine
FR2301380A1 (fr) Machine a mouler les pneumatiques
SE383855B (sv) Drivmaskin for ett bandfordon
SE392123B (sv) Forfarande for framstellning av ett torrt smorjmedel for traddragning
SE389819B (sv) Forfarande for merkning av ett got
SE435619C (sv) Forfarande for framstellning av en 6alfa-deoxitetracyklin
NO141715C (no) Fremgangsmaate for fremstilling av et ildfast foringsmateriale.
SE410011B (sv) Forfarande for framstellning av ett halvhart, magnetiskt material
SE403560B (sv) Belteslas for ett sekerhetsbelte
SE396082B (sv) Forfarande for framstellning av ett mangcelligt streckt foremal
SE426840B (sv) Forfarande for framstellning av ett bituminost bindemedel for byggnadsmaterial
SE418602B (sv) Skrapanirdning for ett transportband

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7404933-9

Effective date: 19880822

Format of ref document f/p: F